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Introduction
The assessment of quality of care is becoming increasingly 
important in healthcare, both globally and in the Nether-
lands. With the transition into a regulated healthcare market 
system in 2006, insurance companies received a central role 
and the shared legal responsibility for the quality of cost-
effective care. This responsibility created the legal need 
to develop a system in which quality of care can be mea-
sured and monitored [1]. Currently, hospital accreditation 
is already based on quality measurements and in the future, 
reimbursement will most likely be based on quality instead 
of price and volume only [2]. The Dutch Minister of Health 
has declared the year 2015 to be the year of transparency, 
thereby stressing the need for reporting of measurable qual-
ity of care [3, 4]. With the increasing importance of trans-
parency, knowledge on quality measurement will become 
vital in daily clinical care. The current manuscript provides 
a comprehensive overview of the Dutch healthcare struc-
ture, quality indicators and the current and future assess-
ment of quality of care in the Netherlands.
Definition of quality indicators
Quality of care has been defined by the Agency for Health-
care Research and Quality of the United States as doing 
the right thing, at the right time, in the right way, for the 
right person—and having the best possible results [5]. The 
aim of measuring quality of care changes with the different 
positions in the healthcare system [6]. Patients aim for the 
best possible outcome and need quality measurements to be 
able to take informed decisions. Healthcare professionals 
aim for the best possible outcome for a maximum number 
of patients and, additionally, need quality measurements to 
benchmark results with other healthcare professionals in 
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order to identify room for improvement. Healthcare insur-
ance companies aim for the best possible (long-term) value 
for the money spent on behalf of their customers (insured 
patients). The government aims to achieve the best pos-
sible public health at a stated budget, while guaranteeing 
financial and physical accessibility and affordability for all 
inhabitants ([7]; Fig. 1).
To accomplish all these goals, quality of care has to be 
measured. In 1966, Donabedian described three different 
types of measurable indicators for quality of care: structure, 
process and outcome indicators ([8]; Tab. 1).
Structure indicators reflect the system and setting in 
which care is delivered and measurements relate directly or 
indirectly to staff expertise or the organisation. For cardiac 
care, examples are PCI volume, availability of a catheteri-
sation laboratory and the educational level of the nursing 
staff. Structure indicators are less likely to be influenced by 
medical professionals and therefore less useful to monitor 
programs for quality improvement. They reflect the average 
results for large groups of providers, not individuals. The 
advantage of these structure indicators is that they are expe-
dient and inexpensive to collect and can be used in plain 
hospital comparisons. Structure indicators are in general 
of limited use in clinical practice although recently a large 
study (n = 457,498) was published in which a relationship 
was found between increased operator/institutional volume 
of PCI procedures and a decrease in adverse outcomes and 
cost of hospitalisation [9]. However, other studies demon-
strated that an increase of volume above a certain thresh-
old is not related to improved outcomes, hence some of 
these structure indicators may be useful to define minimal 
requirements.
Process indicators describe the care patients actually 
receive. Examples for cardiac care are door-to-balloon-
times in patients with a ST-segment elevation myocardial 
infarction and medication prescription according to the 
guidelines [10, 11]. The usefulness of process indicators and 
the association with clinical outcome measures has been 
thoroughly established. In patients with myocardial infarc-
tion, Peterson et al. showed a correlation between processes 
of care and outcome. With every 10 % increase in process 
adherence (for example medication use according to guide-
lines) there was an associated 10 % decrease in in-hospital 
mortality [10]. Another study demonstrated 6 % of hospital-
level variation of 30-day mortality rate to be explained by 
the performance on process measures [12]. In heart failure, 
the relationship between process and outcome is however 
modest. In the OPTIMIZE-HF study, none of the process 
measurements were associated with a decrease in 60- or 
90-day mortality [13]. In case of a proven association, pro-
cess indicators can be useful to monitor if aspects of clini-
cal practice result in an improvement of the quality of care. 
A limitation, however, is that evidence on which processes 
are important for specific procedures is scarce. Importantly, 
although the use of process indicators is known to be effec-
tive in general, they do not mark the quality of care in indi-
vidual patients. For example, patients with symptomatic 
bradycardia after myocardial infarction should not receive a 
beta-blocker, stressing the need for a connection with clini-
cal data, which is more time-consuming.
Quality of care is most effectively measured by clinical 
outcome measures, referring to the effect of the provided care 
on the health status of patients: outcome indicators. Exam-
ples of these are overall mortality rate, hospital readmission 
rate, functional health status and patient satisfaction. Out-
come measurement is considered the most important mea-
surement of quality of care but has to be acquired per patient 
and is therefore relatively time-consuming and expensive. 
In 2013, the Court of Audit (Algemene Rekenkamer) con-
cluded that the quality of most indicator sets is limited and 
that only 7 % of the indicators collected by hospitals were 
outcome indicators [14].
Registration in cardiology in the Netherlands
National quality measurement
National quality measurements are initiatives from govern-
ment, supervision institutions, insurance companies and 
patient organisations. From the perspective of the individual 
hospital and/or cardiology department these initiatives can 
be judged to be external requests for accountability.
The Dutch Healthcare Inspectorate (Inspectie voor de 
Gezondheidszorg, IGZ) has an important task, as described 
in Article 36 of the Healthcare Insurance Act, to verify if 
hospitals meet the minimum level of quality according to 
general healthcare acts and the professional standards as 
defined by the different medical specialists [4]. Verifica-
tion is achieved by surveillance of compliance to the law, 
Fig. 1 Different positions in the health care system in the Netherlands
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costs while improving quality of care. In order to achieve 
this, the Dutch government introduced a regulated health-
care market. Two new important acts were introduced: the 
Healthcare Insurance Act (Zorgverzekeringswet) and the Act 
of Regulation of Healthcare (Wet Marktordening Gezond-
heidszorg) [4, 16]. In the new system the health insurance 
companies play a central role, positioned between patients 
and caregivers, with a shared responsibility to ensure good 
quality and cost-effective care. For the first time it became 
possible for the insurance companies to selectively contract. 
Additional to the responsibility in limiting the rising health-
care costs, insurance companies are required to analyse and 
interpret quality of care provided by caregivers. Article 14 
of the Healthcare Insurance Act, and the general directo-
rial based on this, states that insurance companies share the 
responsibility for efficient and timely healthcare of good 
quality, based on professional standards defined by the sci-
entific professional organisations and healthcare providers. 
The explanatory memorandum of the act states that more 
information on outcome of caregivers will be available in 
the future [17]. Currently, however, more attention is given 
to the volume and cost agreement than to the provided qual-
ity of care [18, 19]. The Dutch Healthcare Authority (Ned-
erlandse Zorgautoriteit, NZa), with its task of overseeing the 
regulated healthcare market, is positive about the increased 
attention to quality of care in contracting during recent 
years [20]. A recent report of the Council for Public Health 
and Healthcare (Raad voor de Volksgezondheid en Zorg, 
RVZ) concluded that health insurance companies have to 
be more transparent about the criteria used for contracting 
care, which caregivers are contracted and how patients were 
involved in the process of contracting [21].
regulations, professional standards and guidelines. The 
Dutch Healthcare Inspectorate focuses on surveillance of 
the highest risks by mostly collecting process and struc-
ture indicators as delivered by the healthcare providers. 
For ST-segment elevation myocardial infarction, outcome, 
structure and process indicators (number of PCI procedures, 
in-hospital or 30-day mortality, door-to-needle time or door-
to-balloon time and the percentage of patients referred for 
cardiac rehabilitation) are acquired. For pacemaker and 
implantable cardioverter defibrillator implantations the 
number of procedure-related complications within 90 days 
has to be registered [15]. The Safety Management System 
(Veiligheidsmanagementsysteem, VMS) is a Dutch patient 
safety program started by the Ministry of Health, Welfare 
and Sport and supported by all hospitals, primarily initiated 
to reduce avoidable patient injuries during hospital admis-
sion. These VMS indicators are now (partly) incorporated in 
the indicators collected by IGZ.
Hospitals use external accreditation programs to prove 
and objectify a certain level of quality of care as well as 
maintenance of quality of care to outsiders. The Netherlands 
Institute for Accreditation in Healthcare (Nederlands Insti-
tuut voor Accreditatie in de Zorg, NIAZ) aims to assure and 
improve Dutch healthcare by using an international accredi-
tation program in which amongst others the VMS indicators 
are embedded. Some hospitals in the Netherlands use the 
international accreditation program, such as the Joint Com-
mission International. Besides quantitative quality indica-
tors, the accreditation systems comprise explicit quality 
policies and quality instruments, such as incident reporting 
and audits.
As described in the introduction, the Dutch healthcare 
system changed in 2006, aiming to reduce rising healthcare 
Table 1 Advantages and disadvantages of outcome, structure and process indicators
Structure indicators Process indicators Outcome indicators
Example PCI volume a year Medical prescription according 
to guidelines
Morbidity and mortality
Availability of cathlab Door-to-balloon-times Functional health status
Education level of the nurses Patient satisfaction
Costs
Advantages Appropriate Reflect care that patients actu-
ally receive
The ‘bottom-line’ of cardiology
If associated with outcome, inexpensive 
proxies of cardiological outcomes
Actionable from provider 
perspective
Outcomes measurement alone may 
improve outcomes
Clear link to quality improve-
ment activities
Disadvantages Most variables not actionable from 
provider perspective
Little information about which 
processes are important for 
specific procedures
Numbers too small to measure with 
adequate procedure-specific outcomes 
for most hospitals and procedures
Imperfect proxies for outcomes reflect 
average results for large groups of pro-
viders, not individuals
Outcome measures that are not proce-
dure-specific less useful for purposes of 
quality improvement
Based on table from Birkmeyer (2004) which is applied on examples from Cardiology [43].
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data from all 74 hospitals in Sweden. In the United States, 
the American College of Cardiology (ACC) initiated the 
National Cardiovascular Data Registry (NCDR®CathPCI), 
which contains information on 12 million patients from 1577 
participating centres [27]. England and Wales collect infor-
mation in the Myocardial Ischaemia National Audit Project 
(MINAP)/National Institute for Cardiovascular Outcomes 
Research (NICOR) database on all patients with acute coro-
nary syndrome, which contains data from all 236 hospitals 
[28, 29]. These registries are useful instruments for address-
ing important clinical questions by retrospectively selecting 
patients for a randomised trial [30]. An overview of other 
international AMI registries is given in Tab. 2. It emphasises 
that sufficient funding is important to ensure a solid registry.
The relationship between registration of quality indicators 
and patient outcomes
Since registration is a time-consuming process, it is impor-
tant to ascertain whether the used quality indicators actu-
ally provide the desired effect of improving quality of care. 
Chatterjee et al. have described three mechanisms by which 
registrations can help to improve patient outcomes [31].
First of all, reporting about quality of care in cardiology 
itself can lead to an incentive for hospital leaders and clini-
cians for improvement. In order to achieve this, it is impor-
tant that results can be shared safely. Studies show that by 
paying attention internally to quality of care, improvement 
in outcomes of healthcare can be observed, which is called 
the Hawthorne effect [32].
Public reporting can also be a powerful incentive for 
clinicians and hospital leaders to improve. Besides, trans-
parency increases confidence of patients in the healthcare 
system. However, public reporting of quality indicators in 
the United States also demonstrated some disadvantages. 
First of all, some studies comparing reporting states and 
non-reporting states show no differences in outcome [33]. A 
further concern of public reporting is that it will lead to risk 
aversion among physicians, deferring patients with more 
complex pathology, as is demonstrated in the literature. 
For example, in the United States, the majority (89 %) of 
interventional cardiologists have reported that the decision 
to intervene in critically ill patients was influenced by par-
ticipating in the reporting of quality measures [33]. A regis-
try confirmed this trend in practice, showing that patients in 
reporting states (e.g. New York) were less likely to undergo 
a PCI procedure if they were in shock [34]. Public report-
ing of CABG mortality in New York led to an increase of 
sicker patients being referred to the adjacent state Ohio 
[35]. Although transparency in quality indicators is increas-
ing in the Netherlands, currently results cannot be linked 
to individual caregivers. The Society for Cardiothoracic 
Surgery in Great Britain and Ireland, in collaboration with 
National quality registries in cardiology
When focussing on cardiology in the Netherlands, there are 
three large national registries: (1) the National Cardiovascu-
lar Data Registry (NCDR), (2) the Supervisory Committee 
for Heart Interventions in the Netherlands (Begeleiding-
scommissie Hartinterventie Nederland, BHN) and (3) Meet-
baar Beter. These registries are all initiated by the healthcare 
professionals involved and funded by the participating hos-
pitals. From the perspective of the hospital and cardiology 
department, these initiatives can be regarded as internal 
quality initiatives, primarily meant to improve the internal 
quality of the individual healthcare provider. Increasingly, 
on request of the government, Healthcare Inspectorate, 
insurance companies and patient organisations, these reg-
isters are used for external accountability as well. The 
NCDR was initiated by the Netherlands Society of Cardi-
ology (Nederlandse Vereniging voor Cardiologie, NVVC) 
and organised in steering committees to develop different 
databases for every area in cardiology [22]. Furthermore, 
the NCDR data are sent to the national Implant Register 
(Medisch Implantatenregister), recently initiated by the 
Ministry of Health, Welfare and Sport [23]. The NCDR is 
NEN7510 certified, an information security certificate. Cur-
rently, data of more than 250,000 device patients are regis-
tered and almost all hospitals (85) participate in NCDR. The 
BHN, a collaboration of cardiothoracic surgery, cardiology, 
anaesthesiology and paediatric cardiology, is a national 
registry of cardiac interventions. The BHN includes data 
of all 16 cardiothoracic centres since 2007 [24]. Meetbaar 
Beter, initiated by the Catharina Hospital, Eindhoven and 
the St. Antonius Hospital, Nieuwegein, is a collaboration of 
currently 12 cardiothoracic centres in the Netherlands. In 
the near future Meetbaar Beter will also include data from 
PCI centres without on-site heart surgery. The Meetbaar 
Beter initiative raises a new Dutch concept of transparency 
reporting: a patient-oriented and physician-driven registry. 
Meetbaar Beter registers patient-outcome data in order to 
optimise clinical processes. Annually, these outcome indi-
cators are analysed and when required, improvements are 
established [25]. Besides these national initiatives, in 16 out 
of 25 regions in the Netherlands, cardiologists collaborate 
with general practitioners, emergency services and patient 
representatives in a regional context which is called NVVC 
Connect. NVVC Connect aims to optimise regional care for 
myocardial infarction, atrial fibrillation and heart failure 
patients [26].
International registries
The first initiatives to register the quality of cardiac care on a 
national basis were started in Sweden and the United States. 
Currently, the Swedish registry SWEDEHEART collects 
Advertisement placed here. 
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the current use and development of quality indicators it is 
also important to take into account that indicators are scien-
tifically acceptable. The indicators should therefore be reli-
able and valid [38].
Reliable means that the indicator provides the same result 
on repeated measures and that the dataset is as complete as 
possible with uniform datasets which are collected in a uni-
form way. Also the Dutch Federation of University Medical 
Centres (Nederlandse Federatie van Universitair Medische 
Centra, NFU) points out in their report on a central vision 
on registration of care the value of a uniform standardised 
dataset. They aim to develop a uniform structure of elemen-
tary data elements and the use of a unified medical language 
based on international standards [39]. The use of universal 
definitions is encouraged by the International Consortium 
for Health Outcomes Measurement (ICHOM), an interna-
tional non-profit organisation with the aim of transforming 
healthcare systems by measuring and reporting patient out-
come [40].
the National Health Service, provides open access to infor-
mation on treatment results of all individual cardiothoracic 
surgeons [36]. To improve transparency and to help patients 
in making informed decisions in the Netherlands, the aim 
of the Dutch government is to publish results of quality of 
care measurements at a national website for patients; www.
kiesbeter.nl [3].
Pay-for-performance is the newest quality improvement 
mechanism, which is gaining attention from healthcare 
leaders and healthcare insurance companies as a strategy 
for maximising quality while controlling costs. Pay-for-
performance implies a shift in paying for quality healthcare 
instead of volume of care, which can be a strong stimulus to 
improve quality [31, 37].
Pitfalls in quality measurement
As addressed before, the results of any measurement must 
be relevant for the different stakeholders in healthcare. In 
Tab. 2 Overview of internal registries in Cardiology internationally, focussed on AMI registries
Country National registry Founded Remarks
Belgium Belgian STEMI project [44, 45]
BIWAC, Belgian Interdisciplin-
ary Working Group on Acute 
Cardiology
2007 Covering: obligatory for all Belgian hospitals; 50-60 % STEMI patients a 
year are registrated
Details: 3000 patients a year
Variables: 25-30
Funding: Public, not linked with reimbursement
PCI registry [46]
BWGIC, Belgian Working Group 
Interventional Cardiology
Covering: all PCI hospitals
Funding: Public, linked with a minimal reimbursement on PCI material
England/Wales MINAP [28, 29]
Myocardial Ischaemia National 
Audit Project
2000 Covering: all 236 acute hospitals in England and Wales for ACS patients 
(STEMI and NSTEMI)
Details: 735 000 patients (2010)
Variables: 123
Funding: Public, by participating hospitals
France FAST-MI [47, 48]
French registry of Acute ST-
segment elevation or non-ST-
segment elevation Myocardial 
Infarction
2005 Covering: 223 centres (60 %). Data collection every five years
Details: 1714 STEMI patients
Variables: 385 in 2010
Funding: Public and private, by French Society of Cardiology and several 
pharmaceutical companies
Sweden SWEDEHEART [28, 49]
A collaboration (since 2008) of 
RISK-HIA, SEPHIA, SCAAR, 
Swedish Heart Surgery Registry 
and Percutaneous Valve Registry
2008 Covering: all 74 hospitals in Sweden for ACS patients undergoing CAG/
PCI, percutaneous valve replacement or heart surgery.
Details: 80.000 new patients each year (3 million in total)
Variables: 106 variables ACS, 75 variables regarding secondary prevention, 
150 variables for patients undergoing coronary angiography/angioplasty, 
100 variables heart surgery.
Funding: Public, by the Swedish Association of Local Authorities and 
Regions. Not linked with reimbursement
Switzerland AMIS Plus [50]
Acute Myocardial Infarction in 
Switzerland
1997 Covering: 106 hospitals ( > 60 %) in Switzerland with STEMI/NSTEMI, 
voluntary participation
Details: 33.040 patients (2010)
Variables: 230 variables




National Cardiovascular Data 
Registry
1998 Covering: 1577 hospitals (90 % of PCI-centres) in the United States
Details: 12 million patients.
Variables: 250 variables.
Funding: reimbursement by insurance companies for participating hospitals
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ance companies provide an increasing focus on measuring 
quality of care. Initial thoughts are that quality indicators are 
connected with a lot of work without appreciating the ben-
efits. Knowledge on and active participation in improving 
quality of care and quality measurements will be essential 
for cardiologists in daily clinical care. Active participation 
also offers major possibilities to design the most optimal 
quality measurement system and to take the lead in improv-
ing quality of care.
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